Tenet Healthcare Corporation

As of June 30, 2026, Tenet Healthcare Corporation carries a market capitalization of 13.20B, placing it among publicly traded companies globally. Its enterprise value stands at 26.44B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Tenet Healthcare Corporation's next confirmed earnings release is scheduled for October 29, 2026.

As of June 30, 2026, Tenet Healthcare Corporation has 80.51M shares outstanding.

As of June 30, 2026, Tenet Healthcare Corporation trades at a trailing price-to-earnings ratio of 7.22. The price-to-sales ratio is 0.71, and the price-to-book ratio stands at 3.24.

As of June 30, 2026, Tenet Healthcare Corporation trades at an EV/EBITDA multiple of 5.56 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.33 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 6.65 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Tenet Healthcare Corporation trades at an EV/FCF ratio of 8.17, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 26.44B versus a market cap of 13.20B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Tenet Healthcare Corporation maintains a current ratio of 1.41, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 152.28, indicating elevated leverage, while an interest coverage ratio of 6.62 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Tenet Healthcare Corporation posted a return on equity (ROE) of 53.31, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 17.13 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 7.55, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 9.13, useful for judging operating efficiency across full business cycles. The company generates approximately 200,658.65 in revenue per employee across its workforce of 98,750.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 11.50 indicates how many times Tenet Healthcare Corporation sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Tenet Healthcare Corporation recorded 604.83M in income tax expense. That works out to an effective tax rate of 17.88, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 3.38B, leaving 1.96B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

These figures are as of the close on October 22, 2026.

Over the twelve months ended June 30, 2026, Tenet Healthcare Corporation generated 19.82B in revenue and converted that into 1.96B in net income, yielding earnings per share of 31.93. EBITDA reached 4.75B, while operating income came in at 3.87B.

As of June 30, 2026, Tenet Healthcare Corporation holds 1.90B in cash and equivalents against 11.60B in total debt, resulting in a net debt position of 9.70B. Total book value stands at 4.08B, with working capital of 1.98B providing operational flexibility.

Tenet Healthcare Corporation produced 3.51B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -868.30M in capital expenditures, free cash flow totaled 2.65B - equivalent to 30.63 per share.

Over the twelve months ended June 30, 2026, Tenet Healthcare Corporation posted a gross margin of 82.83, reflecting its pricing power and cost economics. The operating margin of 19.52 and net profit margin of 9.90 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 18.54, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 21.06, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Tenet Healthcare Corporation shareholders.

Tenet Healthcare Corporation's most recent stock split took place on October 11, 2012 with a 4:1 split ratio.

As of June 30, 2026, Tenet Healthcare Corporation has an Altman Z-Score of 3.10, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.